| Why the Bristol-Myers Share Repurchase Plan Gets a Thumbs Down Eddy Elfenbein submits: I felt the need to do quick post on the news that Bristol-Myers Squibb’s (BMY) board approved a $3 billion share repurchase.Ugh, these announcements make me groan. I loath share buybacks. After watching company after company waste billions of dollars buying their shares, I’ve come to the conclusion that these repurchases are a waste of time and money. I’d much rather see shareholders get more dividends.Complete Story » seekingalpha.com |
No Age Limit on Picky Eating Medical researchers are beginning to turn their attention to adult picky eaters, whose diets can be limited to a handful of foods. online.wsj.com |
Genomic Health to Announce Second Quarter 2010 Financial Results and Host Conference Call on Wednesday, August 4, 2010 (PR Newswire) Genomic Health, Inc. today announced that the company will host a conference call and webcast on Wednesday, August 4 at 4:30 p.m. Eastern Time to discuss its second quarter 2010 financial results. us.rd.yahoo.com |
RepHresh Brilliant pH tampons - Video Introducing RepHresh Brilliant pH Tampons feedproxy.google.com |
Novartis, Immunogen to Work on Cancer Drugs Novartis and Immunogen signed a collaboration deal to develop novel cancer treatments based on the U.S. biotech firm's technology. online.wsj.com |